Cutera Stock

Cutera CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Cutera (CUTRQ) as of Sep 9, 2026 is -68.69 %. In the previous year, Cash Return on Invested Capital (CROIC) was -22.28 % — a change of 208.32% (lower).

CROIC

-68.69 %

YoY

208.32%

Last updated:

Cash Return on Invested Capital (CROIC) of Cutera is 2026 -68.69 % . Cash Return on Invested Capital (CROIC) of Cutera was 2025 -22.28 % . It decreases by 208.32% lower compared to the previous year.

The Cutera CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2016
2.38 USD
Jan 1, 2017
20.69 USD
Jan 1, 2018
-2.54 USD
Jan 1, 2019
-6.83 USD
Jan 1, 2020
-28.15 USD
Jan 1, 2021
0.11 USD
Jan 1, 2022
-22.28 USD
Jan 1, 2023
-68.69 USD
The Cutera CROIC history
YEARCROICYoY
-68.69 %+208.32%
-22.28 %-19,554.65%
0.11 %-100.41%
-28.15 %+312.10%
-6.83 %+168.56%
-2.54 %-112.29%
20.69 %+770.55%
2.38 %-156.33%
-4.22 %-32.33%
-6.24 %
Access this data via the Eulerpool API

Cutera Stock analysis

What does Cutera do? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cutera stock

Cash Return on Invested Capital (CROIC) of Cutera is -68.69 % in 2026.

Cash Return on Invested Capital (CROIC) of Cutera changed from -22.28 % to -68.69 %, representing a 208.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Cutera since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Cutera with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

Profitability — Cutera

All Key Metrics — Cutera